Table 1.
Demographic details of participants and clinical features of patients
| Features/measures | Tourette syndrome (n = 21) | Control (n = 21) | Group difference |
|---|---|---|---|
| Number of males/females | 13/8 | 11/10 | 0.756a |
| Age | 33 (10) | 34 (12) | 0.461b |
| Years of education | 15 (2) | 14 (2) | 0.589b |
| OCD, n | 10 | 0 | - |
| ADHD. n | 6 | 0 | - |
| YGTSS: symptom severity | 27 (8) | - | - |
| YGTSS: impairment | 20 (12) | - | - |
| YGTSS: total (symptom severity and impairment) | 46 (17) | - | - |
| PUTS | 24 (6) | - | - |
| YBOCS | 16 (9) | 6 (6) | <0.001b |
| ASRS | 4 (2) | 1 (1) | <0.001b |
Data are presented as means (SD). Group difference P-values refer to achi-squared or btwo-tailed t-tests. ASRS = Adult ADHD Self-Report Scale; YBOCS = Yale-Brown Obsessive Compulsive Scale.